Search results
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
Zacks via Yahoo Finance· 3 days agoFDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of...
...Biogen, Charge, and Fastly and Encourages Investors to Contact the Firm - Charge Enterprises Inc...
Benzinga· 4 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen
Biogen Inc. Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIIB Investors with Losses to...
Morningstar· 3 days agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...
FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application...
Morningstar· 4 days agoTOKYO and CAMBRIDGE, Mass., June 9, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen ...
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class...
Morningstar· 3 days agoDo you, or did you, own shares of Biogen Inc. (NASDAQ: BIIB)? Did you lose money in your investment in Biogen Inc.
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoLevi & Korsinsky, LLP notifies investors in Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB)...
About 4% of US adults age 65 and older have a dementia diagnosis, survey finds
Reuters· 20 hours agoSome 4% of U.S. adults aged 65 and older say they have been diagnosed with dementia, a rate that reached 13% for those at least 85-years old, according to a report of a national survey released ...
Eli Lilly’s Alzheimer’s drug gets backing from FDA advisers
Market Watch· 3 days agoEli Lilly & Co.’s experimental Alzheimer’s drug donanemab on Monday moved a step closer to U.S....
Petri Dish: Ipsen’s drug approval; Discovery expands local footprint - Boston Business Journal
The Business Journals· 15 hours agoOn Monday, an FDA advisory committee unanimously voted in favor of donanemab, Eli Lilly’s treatment...
Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA...
Benzinga· 2 days agoEli Lilly's donanemab for Alzheimer's disease garners positive FDA committee verdict, prompting analyst's bullish outlook amid comparisons to Biogen's Leqembi.